Published in Ann R Coll Surg Engl on November 01, 1986
Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (1975) 83.56
Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun (1978) 32.33
Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin. Cancer Res (1953) 3.14
Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med (1978) 3.00
Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours. Lancet (1982) 2.51
Localisation of tumour deposits by external scanning after injection of radiolabelled anti-carcinoembryonic antigen. Br Med J (1980) 1.82
Radioimmunodetection of human colorectal cancers by an anti-tumour monoclonal antibody. Lancet (1982) 1.71
Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice. J Exp Med (1983) 1.63
Antitumour reactions of monoclonal antibody against a human osteogenic-sarcoma cell line. Br J Cancer (1981) 1.61
Antibody-directed cytotoxic agents: use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells. Proc Natl Acad Sci U S A (1980) 1.54
Immunoscintigraphy of colon carcinoma. J Nucl Med (1984) 1.31
Improved radioimaging and tumor localization with monoclonal F(ab')2. J Nucl Med (1983) 1.26
Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen. Br Med J (Clin Res Ed) (1982) 1.25
Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma. Cancer Res (1983) 1.16
Liposomally entrapped second antibody improves tumour imaging with radiolabelled (first) antitumour antibody. Lancet (1982) 1.15
Imaging approach in radioimmunodetection. Cancer Res (1980) 1.14
Characteristics of a cell surface antigen defined by an anti-human osteogenic sarcoma monoclonal antibody. Eur J Cancer Clin Oncol (1983) 1.12
The characteristics of blood-borne radiolabels and the effect of anti-mouse IgG antibodies on localization of radiolabeled monoclonal antibody in cancer patients. J Nucl Med (1985) 1.07
Selective cytotoxicity against human tumour cells by a vindesine-monoclonal antibody conjugate. Br J Cancer (1983) 1.02
Localisation of metastatic carcinoma by a radiolabelled monoclonal antibody. Br J Cancer (1983) 0.98
The localization of an anti-tumour monoclonal antibody (791T/36) in gastrointestinal tumours. Br J Surg (1984) 0.97
The localization of antilymphosarcoma antibodies in the Murphy lymphosarcoma of the rat. Cancer Res (1954) 0.97
Imaging of primary and metastatic colorectal cancer using an 111In-labelled antitumour monoclonal antibody (791T/36). Nucl Med Commun (1985) 0.92
Metastatic colon carcinoma detected with radiolabeled F(ab')2 monoclonal antibody fragments. Radiology (1983) 0.91
The localization of human breast carcinomas by radiolabelled monoclonal antibodies. Br J Surg (1984) 0.91
Analysis of a human osteogenic sarcoma antigen and its expression on various human tumour cell lines. Int J Cancer (1984) 0.87
Tumour imaging using an improved method of DTPA-coupled monoclonal antibodies radiolabelled with metallic radionuclides. Lancet (1984) 0.81
The preparation and characterisation of 111In-labelled 791T/36 monoclonal antibody for tumour immunoscintigraphy. Eur J Nucl Med (1985) 0.80
Localisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancer. Br J Cancer (1983) 0.80
Radioimmunolocalization and selection for surgery in recurrent colorectal cancer. Br J Surg (1986) 0.80
Immunolocalization of the murine monoclonal antibody, 791T/36 within primary human colorectal carcinomas and identification of the target antigen. Br J Cancer (1984) 0.78
Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects. Lancet (1989) 4.72
The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut (1999) 2.53
The influence of tumour cell DNA abnormalities on survival in colorectal cancer. Br J Surg (1985) 2.20
Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial. Gut (2001) 1.63
Fecal occult blood screening for colorectal cancer in the general population. Results of a controlled trial. Cancer (1986) 1.40
Early diagnosis of colorectal cancer: a review. J R Soc Med (1984) 1.37
Use of glyceryl trinitrate ointment in the treatment of anal fissure. Br J Surg (1996) 1.20
Transanal endoscopic microsurgery--initial experience from three centres in the United Kingdom. Br J Surg (1996) 1.20
Colon "cast" in a patient with ischaemic colitis. Br J Surg (1987) 1.10
ACPGBI position statement on elective resection for diverticulitis. Colorectal Dis (2011) 1.07
The characteristics of blood-borne radiolabels and the effect of anti-mouse IgG antibodies on localization of radiolabeled monoclonal antibody in cancer patients. J Nucl Med (1985) 1.07
Association of antigen expression and DNA ploidy in human colorectal tumors. Cancer Res (1986) 1.06
Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients. Cancer Immunol Immunother (2003) 1.04
Antigenicity of newly established colorectal carcinoma cell lines. Br J Cancer (1986) 1.00
Partial resection and fenestration in the treatment of polycystic liver disease. Br J Surg (1984) 1.00
Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progression. Br J Cancer (1987) 1.00
Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer. Br J Cancer (1998) 0.99
The localization of an anti-tumour monoclonal antibody (791T/36) in gastrointestinal tumours. Br J Surg (1984) 0.97
Complex perirectal sepsis: clinical classification and imaging. Tech Coloproctol (2006) 0.94
Influence of non-steroidal anti-inflammatory drugs on the outcome of faecal occult blood tests in screening for colorectal cancer. Br Med J (Clin Res Ed) (1987) 0.92
Imaging of primary and metastatic colorectal cancer using an 111In-labelled antitumour monoclonal antibody (791T/36). Nucl Med Commun (1985) 0.92
Defunctioning loop ileostomy and stapled side-to-side closure has low morbidity. Ann R Coll Surg Engl (2001) 0.91
A control trial of faecal occult blood screening for colorectal cancer: 2-year results. Br J Surg (1985) 0.91
Flexible sigmoidoscopy as outpatient procedure. Lancet (1983) 0.89
A study of the reliability of carcinoembryonic antigen blood levels in following the course of colorectal cancer. Clin Oncol (1984) 0.88
Locally advanced breast cancer: long-term results of a randomized trial comparing primary treatment with tamoxifen or radiotherapy in post-menopausal women. Eur J Surg Oncol (1996) 0.86
Biodistribution of a monoclonal antibody-methotrexate conjugate (791T/36-MTX) in patients with colorectal cancer. Int J Cancer Suppl (1988) 0.85
Endoscopic screening of relatives of patients with colorectal cancer. Gut (1998) 0.83
Localization of an anti-CEA monoclonal antibody in colo-rectal carcinoma xenografts. Cancer Immunol Immunother (1985) 0.82
Lateral repair of parastomal hernia. Ann R Coll Surg Engl (2001) 0.81
Fibrin glue for the treatment of fistulae in ano--a method worth sticking to? Colorectal Dis (2009) 0.81
Congenital hypertrophy of the retinal pigment epithelium and mandibular osteomata as markers in familial colorectal cancer. Br J Cancer (1994) 0.80
Magnetic resonance imaging in the management of fistula in ano. Int J Colorectal Dis (1997) 0.79
In vitro binding and in vivo localization in colorectal cancer of a high affinity monoclonal antibody to carcinoembryonic antigen. Br J Surg (1986) 0.79
Five-year prospective study of DNA tumor ploidy and colorectal cancer survival. Cancer (1995) 0.79
V-Y advancement flap for treatment of fistula-in-ano. Dis Colon Rectum (2003) 0.79
Recombinant factor VIIa: a useful tool for life-threatening colonic bleeding. Report of a case. Dis Colon Rectum (2007) 0.78
Immunolocalization of the murine monoclonal antibody, 791T/36 within primary human colorectal carcinomas and identification of the target antigen. Br J Cancer (1984) 0.78
The identification of high and low risk groups for colorectal cancer using rectal mucosal crypt cell production rate (CCPR). Br J Cancer (1993) 0.78
Imaging of primary and metastatic colorectal carcinoma with monoclonal antibody 791T/36 and the therapeutic potential of antibody-drug conjugates. Cancer Detect Prev Suppl (1987) 0.78
Chemical and immunological testing for faecal occult blood in screening subjects at risk of familial colorectal cancer. Gut (1997) 0.77
Screening for colorectal cancer. Eur J Surg Oncol (1985) 0.77
Individuals with a strong family history of colorectal cancer demonstrate abnormal rectal mucosal proliferation. Br J Surg (1993) 0.77
Cell kinetics of the in vitro metaphase arrest technique and the clinical applications. Eur J Cancer Prev (1993) 0.76
Faecal occult blood screening of first degree relatives of patients with colorectal cancer. Int J Colorectal Dis (1986) 0.76
Hartmann's procedure: an appraisal. J R Soc Med (1993) 0.75
Screening for large bowel neoplasms in individuals with a family history of colorectal neoplasms. Br J Surg (1992) 0.75
Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugates. Br J Cancer (1987) 0.75
Histopathological assessment of bleeding from polyps of the colon and rectum. J Clin Pathol (1989) 0.75
Symposium: Screening for colorectal cancer. Int J Colorectal Dis (1986) 0.75
Development of an ELISA to detect early local relapse of colorectal cancer. Br J Cancer (1989) 0.75
The prognostic value of the monoclonal antibody (D5) detected protein, p29, in primary colorectal carcinoma. Br J Cancer (1991) 0.75
Familial adenomatous polyposis. J R Soc Med (1992) 0.75
Wheat fibre, lactulose and rectal mucosal proliferation in individuals with a family history of colorectal cancer. Br J Surg (1994) 0.75
Immunoscintigraphy of colorectal carcinoma with monoclonal antibody 791T/36. Behring Inst Mitt (1984) 0.75
Delayed caecal perforation following flexible fibre-optic sigmoidoscopy. Br J Surg (1984) 0.75
Localization of anti-osteogenic sarcoma monoclonal antibody 791T/36 in a primary human osteogenic sarcoma and its subsequent xenograft in immunodeprived mice. Cancer Immunol Immunother (1985) 0.75
Mural bridging lesions in colonic Crohn's disease. Arch Pathol Lab Med (1993) 0.75
Occult blood screening. Gastroenterology (1985) 0.75
Blood transfusion and survival in colorectal cancer. Dis Colon Rectum (1994) 0.75
Imaging of bone tumors using a monoclonal antibody raised against human osteosarcoma. Cancer (1986) 0.75
Imaging the tumour uptake of radiolabelled antibodies. Br J Radiol (1984) 0.75
DNA content of rectal mucosa and rectal mucosal proliferation in individuals at high risk of colorectal cancer. Eur J Cancer Prev (1994) 0.75
Colonoscopy for all first-degree relatives of patients with colorectal cancer. Br J Surg (1995) 0.75
Surgical approaches in primary sclerosing cholangitis. Aust N Z J Surg (1985) 0.75